Thailand expects to receive 61 million doses of AstraZeneca's (LON:AZN) COVID-19 vaccine this year and has plans to buy an additional 60 million doses in 2022, Reuters news agency reported on Monday.
Thailand's government spokesperson, Anucha Burapachaisri, stated that after a meeting between Thailand's Prime Minister, Prayuth Chan-ocha, and AstraZeneca CEO Pascal Soriot, the company said it would deliver 61 million COVID-19 vaccine doses to Thailand this year.
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses